Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team

Bone Marrow Transplantation

Volumn 37, Issue 5, 2006, Pages 469-477

  Tsuji, Y ^a   Imai, K ^a,b   Kajiwara, M ^a,c   Aoki, Y ^a   Isoda, T ^a   Tomizawa, D ^a   Imai, M ^a   Ito, S ^a   Maeda, H ^a   Minegishi, Y ^a   Ohkawa, H ^a   Yata, J ^a   Sasaki, N ^d   Kogawa, K ^b   Nagasawa, M ^a   Morio, T ^a   Nonoyama, S ^b   Mizutani, S ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cord blood transplantation; Hematopoietic stem cell transplantation; Primary immunodeficiency disease; Severe combined immunodeficiency; Wiskott Aldrich syndrome; X linked hyper IgM syndrome

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BCG VACCINE; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUCONAZOLE; FLUDARABINE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN G; METHOTREXATE; METHYLPREDNISOLONE; POLYMYXIN; PREDNISOLONE; QUINOLONE DERIVATIVE; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHIMERA; CHROMOSOME DISORDER; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; FATALITY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HYPERIMMUNOGLOBULINEMIA M; IMMUNE DEFICIENCY; INFECTION; LIVING DONOR; LYMPHOCYTE DEPLETION; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RELATIVE; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME SERIES ANALYSIS; TREATMENT OUTCOME; WHOLE BODY RADIATION; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFECTION; LYMPHOCYTE DEPLETION; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 33645319762     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705273     Document Type: Article

References (30)

1. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508-516.
2. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: Report of the European experience 1968-99. Lancet 2003; 361: 553-560.
3. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990; 336: 850-854.
4. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G et al. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123: 564-572.
5. Hale G, Waldmann H. Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users. Blood 1998; 91: 3079-3083.
6. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
7. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577.
8. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-1193.
9. Takagi S, Minakuchi J, Okawa H, Yata J. Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency. J Clin Immunol 1989; 9: 39-47.
10. Nagasawa M, Morio T, Takagi S, Yata J. Generation and function of gamma delta T cells after allogeneic bone marrow transplantation in humans: comparison in absence or presence of HLA-matched or mismatched thymus. Acta Paediatr Jpn 1991; 33: 146-158.
11. Nagasawa M, Morio T, Takagi S, Yata J. Differences of LAK-activity and IL-2 responsiveness between alpha/beta and gamma/delta T cells which developed after thymus transplantation. Acta Paediatr Jpn 1994; 36: 396-403.
12. Tomizawa D, Aoki Y, Nagasawa M, Morio T, Kajiwara M, Sekine T et al. Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome. Eur J Hematol 2005; 75: 441-444.
13. Tomizawa D, Imai K, Ito S, Kajiwara M, Minegishi Y, Nagasawa M et al. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: A single center experience. Am J Hematol 2004; 76: 33-39.
14. Nagasawa M, Imai M, Imai K, Itoh S, Kajiwara M, Morio T et al. In vivo class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient. Am J Hematol 2000; 65: 176-177.
15. Minegishi Y, Ishii N, Maeda H, Takagi S, Tsuchida M, Okawa H et al. Three novel mutations in the interleukin-2 receptor gamma chain gene in four Japanese patients with X-linked severe combined immunodeficiency. Hum Genet 1995; 96: 681-683.
16. Wada T, Toma T, Okamoto H, Kasahara Y, Koizumi S, Agematsu K et al. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 2005; 106: 2099-2101.
17. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M et al. Clinical course of patients with WASP gene mutations. Blood 2004; 103: 456-464.
18. Bolinger AM, Zangwill AB, Slattery JT, Glidden D, DeSantes K, Heyn L et al. An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease. Bone Marrow Transplant 2000; 25: 925-930.
19. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B et al. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983;.61: 341-348.
20. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
21. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
22. Nagasawa M, Maeda H, Okawa H, Yata J. Pulmonary miliary tuberculosis and T-cell abnormalities in a severe combined immunodeficient patient reconstituted with haploidentical bone marrow transplantation. Int J Hematol 1994; 59: 303-309.
23. Bittencourt H RV, Chevret S. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 99: 2726-2733.
24. Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005; 105: 879-885.
25. Gennery AR, Khawaja K, Veys P, Bredius RG, Notarangelo LD, Mazzolari E et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: A survey of the European experience, 1993-2002. Blood 2004; 103: 1152-1157.
26. Lenarsky C, Weinberg K, Kohn DB, Parkman R. Unrelated donor BMT for Wiskott-Aldrich syndrome. Bone Marrow Transplant 1993; 12: 145-147.
27. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: Collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598-1603.
28. Knutsen AP, Steffen M, Wassmer K, Wall DA. Umbilical cord blood transplantation in Wiskott-Aldrich syndrome. J Pediatr 2003; 142: 519-523.
29. Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 2005; 115: 391-398.
30. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002; 99: 872-878.